Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) — Tangible Net Worth Ratio
Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) has a Tangible Net Worth Ratio of 95.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥54.64 Million) from net assets (CN¥1.12 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Anhui Sunhere Pharmaceutical Excipients (300452) shareholders funds for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Anhui Sunhere Pharmaceutical Excipients Co Ltd Tangible Net Worth Ratio (2011–2025)
This chart shows how Anhui Sunhere Pharmaceutical Excipients Co Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 95.1%, reflecting net assets of CN¥1.12 Billion with intangible assets of CN¥54.64 Million CNY. Also explore 300452 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Anhui Sunhere Pharmaceutical Excipients Co Ltd (2011–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Anhui Sunhere Pharmaceutical Excipients Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Anhui Sunhere Pharmaceutical Excipients stock valuation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | CN¥1.07 Billion | CN¥54.99 Million | CN¥1.71 Billion | ▲ +0.1 pp |
| 2024 | 94.7% | CN¥975.30 Million | CN¥51.22 Million | CN¥1.56 Billion | ▲ +0.3 pp |
| 2023 | 94.4% | CN¥935.25 Million | CN¥52.37 Million | CN¥1.54 Billion | ▲ +1.2 pp |
| 2022 | 93.2% | CN¥788.62 Million | CN¥53.66 Million | CN¥1.18 Billion | ▲ +0.9 pp |
| 2021 | 92.3% | CN¥705.92 Million | CN¥54.48 Million | CN¥962.58 Million | ▼ -2.2 pp |
| 2020 | 94.5% | CN¥655.17 Million | CN¥36.19 Million | CN¥900.87 Million | ▲ +0.7 pp |
| 2019 | 93.8% | CN¥596.57 Million | CN¥37.03 Million | CN¥810.17 Million | ▲ +0.6 pp |
| 2018 | 93.2% | CN¥557.89 Million | CN¥37.89 Million | CN¥709.75 Million | ▲ +1.0 pp |
| 2017 | 92.3% | CN¥500.23 Million | CN¥38.75 Million | CN¥666.40 Million | ▼ -1.6 pp |
| 2016 | 93.8% | CN¥402.70 Million | CN¥24.95 Million | CN¥512.85 Million | ▲ +0.8 pp |
| 2015 | 93.0% | CN¥363.20 Million | CN¥25.52 Million | CN¥458.06 Million | ▲ +7.7 pp |
| 2014 | 85.3% | CN¥177.20 Million | CN¥26.09 Million | CN¥266.39 Million | ▲ +3.1 pp |
| 2013 | 82.1% | CN¥149.23 Million | CN¥26.66 Million | CN¥233.58 Million | ▲ +4.6 pp |
| 2012 | 77.5% | CN¥121.17 Million | CN¥27.23 Million | CN¥212.20 Million | ▲ +6.4 pp |
| 2011 | 71.1% | CN¥95.96 Million | CN¥27.70 Million | CN¥121.51 Million | — |